Evidence map›Paper›PMID 22116411›Full record

Trial reportPsychotherapy and psychosomatics2012

Higher executive control and visual memory performance predict treatment completion in borderline personality disorder.

Eric A Fertuck, John Keilp, Inkyung Song, Melissa C Morris, Scott T Wilson, Beth S Brodsky, Barbara Stanley

Open access · bronzeAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Psychotherapy and psychosomatics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
3.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Non-response to psychotherapy for borderline personality disorder: A systematic review.The Australian and New Zealand journal of psychiatry · 2022
    Pooled it
  3. Psychological therapies for people with borderline personality disorder.The Cochrane database of systematic reviews · 2020
    Pooled it
  4. Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Eric A FertuckSubprogram in Clinical Psychology, Department of Psychology, City University of New York, New York 10031, USA. efertuck@ccny.cuny.edu
John Keilp
Inkyung Song
Melissa C Morris
Scott T Wilson
Beth S Brodsky
Barbara Stanley
Columbia University · USCity University of New York · USNew York State Psychiatric InstituteUniversity of Florida · US

Funding

TREATING SUICIDAL BEHAVIOR AND SELF MUTILATION IN BPDR01MH061017 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI STANLEY, BARBARA · 2000 to 2012
$7.0M
DCIPS: Intervention with High Suicide Risk IndividualsP20AA015630 · NIAAA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI STANLEY, BARBARA · 2004 to 2009
$3.7M
Prospective Study of Suicidal Behavior in BPDR01MH062665 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI STANLEY, BARBARA · 2002 to 2006
$1.5M
Social Neuroscience of Borderline Personality DisorderK23MH077044 · NIMH · RESEARCH FOUNDATION FOR MENTAL HYGIENE · PI FERTUCK, ERIC A · 2008 to 2012
$926k
NIAAA NIH HHS P20 AA015630NIMH NIH HHS K23 MH077044NIMH NIH HHS K23MH077044NIMH NIH HHS MH62665NIMH NIH HHS R01 MH061017NIMH NIH HHS R01 MH062665
6 · The paper itself

Abstract

backgroundNon-completion of a prescribed course of treatment occurs in 20-60% of individuals diagnosed with borderline personality disorder (BPD). While symptom severity, personality traits and environmental factors have been implicated as predictors of treatment non-completion (TNC), there have been no studies of neuropsychological predictors in this population.

methodsFrom a randomized controlled trial, a subsample of 31, unmedicated outpatients diagnosed with BPD with recent self-injurious behavior was assessed on 5 neuropsychological domains. Patients were also assessed for general IQ, demographic and other salient clinical variables. Patients were randomized to one of four treatment conditions, which lasted up to 1 year. Number of weeks in treatment (WIT) up to 1 year was utilized as the index of TNC.

resultsThirty-three percent of the subsample (n = 12) did not complete 1 year of treatment. However, more WIT were predicted by better baseline executive control (Trails B; p < 0.01) and visual memory performance (Benton visual retention; p < 0.001); other neuropsychological domains did not predict WIT.

conclusionIn the treatment of outpatients with BPD, better executive control and visual memory performance predict more WIT. Assessing and addressing these neurocognitive factors in treatment may reduce TNC in this high-risk population.

Indexed as

AdultAmbulatory CareAttentionBehavior TherapyBorderline Personality DisorderDepressionExecutive FunctionFemaleFluoxetineHumansImpulsive BehaviorLinear ModelsMaleMemory, Short-TermNeuropsychological TestsPatient ComplianceFluoxetinePlacebosSelective Serotonin Reuptake Inhibitors

Identifiers

PMID22116411
PMCPMC3242704
OpenAlexW2015984802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.